Avertix, Maker Of Only FDA-Approved Implantable Heart Attack Warning System, To Become Publicly Traded Via Merger With BIOS Acquisition Corporation
- Transaction values Avertix at an enterprise value of $195 million- Avertix developed the Guardian™ System, the first and only FDA-approved solution designed to detect and warn patients of cardiac events,